Skip to content
Search

Latest Stories

LloydsPharmacy Clinical Homecare awarded overall ‘Good’ rating by CQC

LloydsPharmacy Clinical Homecare has been awarded ‘Good’ rating in all five domains- safe, effective, caring, responsive and well-led by the Care Quality Commission (CQC).

This is recognition of the huge turnaround the service has made in such a short space of time. The Harlow site was inspected in October 2022.


Established in 1975, LloydsPharmacy Clinical Homecare is one of the most experienced providers of clinical homecare, and delivers care to more than 100,000 patients in the comfort of their home, at work, or in the community – ranging from straightforward delivery of medication to specialist nursing for complex conditions. The provider was credited with having ‘significantly improved’ following negative feedback from the regulators last year.

In particular, it was reported that ‘all staff were committed to continually learning and improving services. They had a good understanding of quality improvement methods and the skills to use them, and leaders encouraged innovation and participation in research’.

Inspectors highlighted LloydsPharmacy Clinical Homecare’s Remote Nurse Training service, which is for patients with long-term conditions. ‘The service has enabled patients, through telephone training, to self-inject their ongoing treatments. It has facilitated greater independence for patients and has reduced the risk of transmission of the COVID-19 virus to a patient group that were considered vulnerable.’

With a success rate of 99%, the training programme was rolled out nationally across 13 different biological therapies. The service was a finalist in the Nursing Times Awards 2020 in the category of Managing Long-term Conditions.

Nick Davis, CEO of LloydsPharmacy Clinical Homecare, said: “The CQC’s report reflects how far we have come in the last year. Every single person who is part of the LloydsPharmacy Clinical Homecare team - from our front-line nurses and healthcare assistants to our senior management team, has worked extremely hard to bring the service back to a standard that we can be proud of, however, we will not rest on our laurels as we strive to do even better each day.

“We are all dedicated to our programme of continuous improvement, and the regulator’s feedback is extremely important to us. The inspectors have also provided valuable guidance on where we can make even more progress, and it will help us reach our goal of being rated outstanding in the near future.”

 

More For You

Professor Sir Stephen Powis at a press briefing

Professor Sir Stephen Powis, was appointed national medical director of NHS England in 2018

NHS

NHS England’s top doctor to step down following Amanda Pritchard’s resignation

Just a week after NHS England chief executive Amanda Pritchard announced her resignation, the organisation’s national medical director, Professor Sir Stephen Powis, has confirmed he will step down this summer after more than seven years in the role.

In a statement released on Thursday, Professor Powis revealed that he had informed Pritchard of his intention to leave in a letter back in January.

Keep ReadingShow less
PDA calls on GP practices to use funding boost to improve job security for pharmacists

Now, it is time to focus on the community pharmacy contract

gettyimages

PDA urges GP practices to ensure funding boost supports employed pharmacists

The Pharmacists' Defence Association (PDA) has called on GP practicesto ensure that all healthcare professionals they employ, including pharmacists, benefit from the 7.2% funding boost they received under a newly agreed contract.

GP employers are encouraged to improve “job security, pay and conditions” for employees with this increased funding.

Keep ReadingShow less
Fourth Shift: Investment in Innovative Medicines Crucial for NHS 10-Year Plan Success

Medicines should be viewed as an investment rather than a cost

gettyimages

ABPI wants to see a ‘fourth shift’ in NHS 10-Year Health Plan


The Association of the British Pharmaceutical Industry (ABPI) has called on the government to increase investment in innovative medicines and vaccines, describing it as a crucial “fourth shift” necessary to ensure the NHS is fit for the future.

Keep ReadingShow less
Asda pharmacy launches UK’s first adult earache service

Asda makes ear health more accessible for everyone

gettyimages

Asda pharmacy launches £25 adult earache service

British supermarket chain Asda has launched the “UK’s first” adult earache service, aiming to reduce the burden on NHS services by eliminating the need for a GP appointment.

Priced at £25, the service allows patients aged 18 and over to book same-day appointments with qualified Asda pharmacists at any of its 226 pharmacies in England.

Keep ReadingShow less
Dr Penelope Dash new chair of NHS England

Dr Penny Dash is currently the chair of the NHS North West London Integrated Care Board

parliamentlive

Dr Penelope Dash appointed as new chair of NHS England

Dr Penny Dash has been appointed as the next chair of NHS England following an open public appointment process.

She will succeed Richard Meddings, who is set to step down next month, and her four-year term begins on April 1, 2025.

Keep ReadingShow less